KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CareDx (CDNA) Return on Sales (2016 - 2026)

CareDx's Return on Sales history spans 14 years, with the latest figure at 0.0% for Q1 2026.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q1 2026 for CareDx, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for CDNA hit a ceiling of 0.01% in Q4 2024 and a floor of 0.02% in Q4 2023.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2022.
  • Biggest five-year swings in Return on Sales: decreased -2bps in 2023 and later grew 3bps in 2024.
  • Tracing CDNA's Return on Sales over 5 years: stood at 0.0% in 2022, then crashed by -710bps to 0.02% in 2023, then surged by 156bps to 0.01% in 2024, then crashed by -104bps to 0.0% in 2025, then surged by 163bps to 0.0% in 2026.
  • Business Quant data shows Return on Sales for CDNA at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.